Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1976-07-28
1977-10-25
Miller, Edward A.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 260112R, 424 15, 424 12, A61K 4300, G01N 3316, G21H 502
Patent
active
040556336
ABSTRACT:
An immunoassay for the polypeptidic thymic hormone thymopoietin (thymin) is described. Determination of thymopoietin levels in biological fluids provides a useful diagnostic test for myasthenia gravis (elevated levels), immune deficiency diseases (reduced levels), immunologically mediated diseases such as rheumatoid arthritis, systemic lupus erythematosus and allergy (reduced levels) cancer (reduced levels), malnutrition (reduced levels) and infections (reduced levels). The present assay is also useful as a monitor of the effectiveness of therapy in each of the aforementioned types of disease states.
REFERENCES:
patent: 3790663 (1974-02-01), Garrison et al.
patent: 3897212 (1975-07-01), Leon et al.
patent: 3988430 (1976-10-01), Dixon et al.
Basch et al., Chemical Abstracts, vol. 81, No. 5, Aug. 5, 1974, p. 66, Abstract No. 21306s.
Scheib et al., Chemical Abstracts, vol. 83, No. 7, Aug. 18, 1975, p. 334, Abstract No. 56643t.
Miller Edward A.
Nucker Christine M.
Sloan-Kettering Institute for Cancer Research
LandOfFree
Immunoassay for thymopoietin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoassay for thymopoietin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoassay for thymopoietin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-123248